Vanguard Group Inc Avidity Biosciences, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 9,226,884 shares of RNA stock, worth $403 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,226,884

Previous 5,943,682 55.24%

Holding current value

$403 Million

Previous $243 Million 74.54%

% of portfolio

0.01%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$37.21 - $48.14 $122 Million - $158 Million	3,283,202 Added 55.24%	9,226,884 $424 Million
Q2 2024 Aug 13, 2024	BUY	$22.73 - $40.85 $47.7 Million - $85.7 Million	2,098,610 Added 54.58%	5,943,682 $243 Million
Q1 2024 May 10, 2024	SELL	$9.16 - $25.52 $1.81 Million - $5.06 Million	-198,107 Reduced 4.9%	3,845,072 $98.1 Million
Q4 2023 Feb 14, 2024	BUY	$4.87 - $9.37 $139,715 - $268,815	28,689 Added 0.71%	4,043,179 $36.6 Million
Q3 2023 Nov 14, 2023	BUY	$6.3 - $11.35 $298,021 - $536,911	47,305 Added 1.19%	4,014,490 $25.6 Million
Q2 2023 Aug 14, 2023	BUY	$10.62 - $17.34 $5.16 Million - $8.42 Million	485,468 Added 13.94%	3,967,185 $44 Million
Q1 2023 May 15, 2023	BUY	$15.35 - $25.65 $170,246 - $284,484	11,091 Added 0.32%	3,481,717 $53.4 Million
Q4 2022 Feb 10, 2023	BUY	$10.06 - $22.66 $7.77 Million - $17.5 Million	772,250 Added 28.62%	3,470,626 $77 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $23.43 $4.27 Million - $6.47 Million	276,254 Added 11.41%	2,698,376 $44.1 Million
Q2 2022 Aug 12, 2022	BUY	$11.18 - $20.5 $1.38 Million - $2.54 Million	123,759 Added 5.38%	2,422,122 $35.2 Million
Q1 2022 May 13, 2022	BUY	$14.2 - $23.78 $4.19 Million - $7.01 Million	294,791 Added 14.71%	2,298,363 $42.5 Million
Q4 2021 Feb 14, 2022	BUY	$20.4 - $28.66 $1.24 Million - $1.75 Million	60,959 Added 3.14%	2,003,572 $47.6 Million
Q3 2021 Nov 12, 2021	BUY	$18.16 - $25.21 $12.2 Million - $16.9 Million	670,815 Added 52.75%	1,942,613 $47.8 Million
Q2 2021 Aug 13, 2021	BUY	$19.62 - $29.26 $25 Million - $37.2 Million	1,271,798 New	1,271,798 $31.4 Million

Others Institutions Holding RNA

# of Institutions

256

Shares Held

107M

Call Options Held

224K

Put Options Held

161K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.28B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Avidity Biosciences, Inc. Transaction History